{"SPADE_N_13528": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_N_13528", "Peptide Name": "CCL28 (MEC; SCYA28; CCK1; cytokine, kinocidins; antimicrobial protein; natural AMPs; human, primates, mammals, animals)", "Source": "saliva, milk, epithelial cells/mucosal tissues,Homo sapiens", "Family": "Not found", "Gene": "Not found", "Sequence": "MQQRGLAIVALAVCAALHASEAILPIASSCCTEVSHHISRRLLERVNMCRIQRADGDCDLAAVILHVKRRRICVSPHNHTVKQWMKVQAAKKNGKGNVCHRKKHHGKRNSNRAHQGKHETYGHKTPY", "Sequence Length": 127, "UniProt Entry": "Reference ID: 6CWS", "Protein Existence": "Not found", "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Antifungal", "Antifungal", "Antiparasitic", "Chemotactic"], "Target Organism": "Not found", "Hemolytic Activity": "Not found", "Cytotoxicity": "Not found", "Binding Target": "Not found", "Linear/Cyclic": "Not found", "N-terminal Modification": "Not found", "C-terminal Modification": "Not found", "Stereochemistry": "Not found", "Structure Description": "Not found", "Formula": "Not found", "Mass": 14279.49, "PI": 10.23, "Hydrophobicity": -0.54, "Half Life": "Not found", "Function": "Not found", "Literature": [{"Author": "Hieshima K, Ohtani H, Shibano M, Izawa D, Nakayama T, Kawasaki Y, Shiba F, Shiota M, Katou F, Saito T, Yoshie O.2003", "Reference": "J Immunol. 2003 Feb 1;170(3):1452-61.Pub-Med.", "Title": "CCL28 has dual roles in mucosal immunity as a chemokine with broad-spectrum antimicrobial activity."}], "Frequent Amino Acids": "AHR", "Absent Amino Acids": "FOU", "Basic Residues": 35, "Acidic Residues": 7, "Hydrophobic Residues": 48, "Polar Residues": 91, "Positive Residues": 35, "Negative Residues": 7, "Net Charge": 28, "Comments": "Antimicrobial activity: Active against C. albicans, P. aeruginosa, K. pneumoniae, S. mutans, S. pyogenes, and S. aureus (IC50 0.4-3 uM).Salt-sensitive: Activity is salt-sensitive.SAR: The C-terminal 28-aa peptide of human CCL28 also displayed a selective candidacidal activity. It is also active against parasite L. mexicana in vitro (SÃ¶birk SK et al 2013).Structure: The 3D structure of CCL-28 has been determined by NMR spectroscopy. Three beta strands and two helical region were found. The C-terminal region is disordered (Thomas MA et al., 2018).You can rotate, zoom, and view the 3D structureherein the PDB. Updated 7/2018; Validated 7/2021", "Similar Sequences": [{"SPADE_ID": "SPADE_N_15709", "Similarity": 1.0, "Sequence": "SEAILPIASSCCTEVSHHISRRLLERVNMCRIQRADGDCDLAAVILHVKRRRICVSPHHTVKQWMKVQAAKKNGKGNVCHRKKHHGKRNSNRAHQGKHETYGHKTPY"}, {"SPADE_ID": "SPADE_N_09476", "Similarity": 1.0, "Sequence": "HRKKHHGKRNSNRAHQGKHETYGHKTPY"}, {"SPADE_ID": "SPADE_UN_27858", "Similarity": 1.0, "Sequence": "HRKKHHGKRNSNRAHQGKHETYGHKTPY"}]}}}